Skip to content

TBPH - Theravance Biopharma, Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchT

Theravance Biopharma Inc

TBPH · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

T

TBPHTheravance Biopharma Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $21.03
52-wk low: $13.08
Prev close: $19.00
Mkt cap: $882.1M
P/E: 16.3x
Fwd P/E: 5.6x

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$164.0M

TS
Two Sigma
Q2 2026 13F
$20.8M
position
DS
D.E. Shaw
Q2 2026 13F

Earnings

Reported Aug 10, 2026

Earnings came in 50.0% below what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

Fairly priced and profitable.

Net margin: 51.6%
P/E: 16.34
Forward P/E: 5.59
Market cap: $882M

Valuation

P/S8.46
P/B3.04

Quality

Operating margin8.9%

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: TBPH
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $882.10M
Beta: 0.25

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

Beta

0.25

P/S

8.5x

P/B

3.0x

Profit margin

+51.6%

Op margin

+8.9%

ROE

+20.9%

$20.2M

position

CI

Citadel

Ken Griffin · Q2 2026 13F

$8.6M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for TBPH

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

$0.07-50.0%

$0.14 expected

Next report

What the street expects next

EPS expected

$0.20

$0.20 to $0.20

Revenue expected

$21.6M

4 analysts

ROE20.9%

ROA1.3%

Growth

Beta0.25